← All organizations

Alzheon Inc.

For profitWebsite ↗

Also known as: Alzheon Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Apr 2, 2024

Timeline

2010s

Jan 1, 2013
Alzheon Inc.— Founded

Drugs by trial phase (1 distinct, 5 trials)

Phase 3 (1 own, 0 via acquisition)

alz-801

Indications

Studied for

Alzheimer Disease

Recent trials (8)

NCT06304883Lead sponsorPhase 3Apr 2, 2024
NCT06304883OfficialPhase 3Apr 2, 2024
NCT04770220Lead sponsorPhase 3May 19, 2021
NCT04770220Overall official - principal investigatorPhase 3May 19, 2021
NCT04693520Lead sponsorPhase 2Sep 30, 2020
NCT04693520Study directorPhase 2Sep 30, 2020
NCT04157712Lead sponsorPhase 1Sep 26, 2015
NCT04585347Lead sponsorPhase 1Sep 16, 2015

Details

Founded: Framingham, MA, US Jan 1, 2013
Last known activity: Apr 2, 2024